Showing results (201-210 of 365) with videos related to
Sort By:
Pageof 37
Immunotargets and Therapy|February 4, 2021
Current Insights into Immunotherapy Approaches for Food AllergyJessica D Macdougall, A Wesley Burks, Edwin H KimImmunotargets and Therapy|July 11, 2018
Multiple effects of CD40-CD40L axis in immunity against infection and cancerAnjuman Ara, Khawaja Ashfaque Ahmed, Jim XiangImmunotargets and Therapy|August 15, 2018
Review of checkpoint immunotherapy for the management of non-small cell lung cancerShine Raju, Ranjit Joseph, Sameep SehgalImmunotargets and Therapy|February 9, 2018
Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancerOlivier Belzile, Xianming Huang, Jian Gong, et al.Immunotargets and Therapy|December 13, 2018
Alteration of gene expression profile in CD3+ T-cells after downregulating MALT1Xu Wang, Shuai Lu, Yankai Xiao, et al.Immunotargets and Therapy|March 25, 2026
Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung CancerEleonora Gariazzo, Francesca Colamartini, Martina Ubaldi, et al.Immunotargets and Therapy|March 25, 2026
The Role of PD-L1 in Lung Cancer: From Biology to Clinical ApplicationHassan Lamghari, Mehdi KarkouriImmunotargets and Therapy|June 3, 2026
Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple MyelomaSuiping Liu, Jieying Wu, Jiayu Liu, et al.Immunotargets and Therapy|May 27, 2026
Development of an Active Chimeric IL13Rα2 ADC for Diffuse Intrinsic Pontine GliomaXiaolei Lian, Victoria J Allanson, Samuel V Rasmussen, et al.Immunotargets and Therapy|April 14, 2026
Cryoablation Plus Immune Checkpoint Inhibitors Enhanced Dendritic Cell and T Cell Activation in TNBC Murine ModelFlavia Sardela de Miranda, Rachel L Babcock, Maria F Mahecha, et al.Pageof 37